A retrospective study evaluates the use of antibiotic lock therapy as a catheter-sparing strategy in pediatric patients with hematologic and oncologic diseases.

The shortages trace to manufacturing problems, shipping delays and decisions by some companies to stop making the medicines, according to the U.S. Food and Drug Administration (FDA).

The new presentation is expected to provide an additional self-administration option for patients with polycythemia vera.

A preliminary injunction preserves higher federal student loan limits for eligible NP and PA students while litigation continues.

Current guidelines recommend strategies such as the use of pH-balanced cleansers, proactive daily moisturization, and early dermatologic consultation when a patient starts to show early signs of ...

Investigators assessed whether machine learning models provide accurate, individualized risk predictions for major 30-day postoperative complications following glossectomy.

Backed by phase 3 PATINA trial data, Ibrance is the first and only CDK4/6 inhibitor available for HR+ metastatic disease across all HER2 patient profiles.

Stockholm3, which combines prostate-specific antigen (PSA), plasma protein biomarkers, polygenic risk, and clinical factors offers greater clinical net benefit for detecting clinically significant ...